Last year our community funded a project to regrow tooth enamel - regenerative tech that has never been done before Super cool to see milestones being hit by the team; they've successfully produced the material in a living organism! Lab report live → molecule.xyz/ipts/donna/...

Last year our community funded a project to regrow tooth enamel - regenerative tech that has never been done before Super cool to see milestones being hit by the team; they've successfully produced the material in a living organism! Full lab report is live at molecule.xyz/ipts/donna/...

Cofounder of @xai is going founder mode on his health His months will be spent studying biology, mapping the IP landscape, backing serious scientists, and treating every decision like a startup When the system has no incentives to innovate, individuals have to.. x.com/TheGregYang...

Dr. Daniel Bar created a video explainer covering the background & progress of his Alzheimer's project Accessibility in science is critical -- it's great to see researchers making the time and effort to communicate with the DeSci community Give it a watch at molecule.xyz! x.com/AB4AD_/stat...

We've teamed up with a local biotech hub in South Africa and are hosting an event in Cape Town -- Thu 5 Feb True decentralization means supporting science hubs globally, & Africa has the fastest-growing Web3-native population in the world Ticket link ⤵ www.quicket.co.za/events/3554...

One of the biggest open questions for DeSci has been -- can it take a compound all the way to the clinic? @Neuron_Percepta and @Cerebrum_DAO just received ethics approval to launch their first human study Read the full update on molecule.xyz x.com/Neuron_Perc...

Science, but put it onchain Alzheimer's project by 2 senior scientists at @UniBasel → targeting the root cause of protein clusters in the brain → funded by crypto → breezing through milestones → publishing updates on Molecule molecule.xyz/ipts/fidel x.com/Transfideli...

Most people don’t realize common infections like herpes or gum disease might increase your risk of Alzheimer’s AB4AD, a DeSci-funded research team, has just released their data exploring this connection - live on Molecule Only in DeSci x.com/AB4AD_/stat...

Some of the best drug candidates fail for one simple reason: delivery. They never reach the right cells, tissues, or compartments Fission Bio is building around this challenge & is making progress Their full scientific update is live on moleucle.xyz x.com/FissionBioD...

Our staff just published a paper in Frontiers in Blockchain analyzing outcomes from our DeSci EDU course → one of the first structured attempts to measure how people actually learn DeSci

Incredible to see legacy media getting on board with Decentralized Science Massive congratulations to the @athena_DAO_ community! x.com/athena_DAO_...

News out of SF this week -- @EliLillyandCo & @nvidia announce a $1bn co-investment in AI drug discovery, two months after partnering to build pharma's most powerful supercomputer. The scale of what is possible with science grows day by day, and we're all primed to enact it.

Who is the most motivated person to cure a disease? The patient. Current drug development models assign patients as trial subjects rather than collaborators. One has to ask, what happens when patients are given a seat at the table? x.com/JackHadfiel...

Our Chief Commercial Officer shares how Molecule is bridging researchers, capital, and IP to scale breakthroughs. Strong signal for where DeSci is headed. The team at @DeSciNews is cooking 💥 x.com/DeSciNews/s...

Longevity researchers @Mykalt45 breaks down new findings that directly support the core thesis behind his project @vitarnabio It's great to see fresh publications validating a thesis DeSci has funded years ago & have world-class researchers available to explain it to us! x.com/Mykalt45/st...

Biotech is waking up. Founders are shipping, discovery cycles are compressing, and capital is flowing into AI-driven discovery, programmable cells, and platform science.↓

2026 is the year of changing science.

From lab bench to licensing… then maybe, years later, the world sees your science. Michael Torres from @artan_bio explains why traditional pathways make it hard to fund and share research, and how DeSci opens an alternative path. youtu.be/GBrmoFELIJc

15 years + $15M for 3 years of use. Discovery isn't the problem -- the design for discovery itself is. @chandradhish & @EMcCarthyPage explain why the current Pharma model is failing and what comes next. Watch the full episode here: youtu.be/u5sLJ6ys6V0

From our screener: $VITA-FAST – restoring the cell's natural cleanup system. Backed by @vitadao, the project targets autophagy, the process that keeps cells young, resilient, and functional ↓

2025 was a transformative year for Molecule After five years of experiments, 2025 was a convergence year -- shipping the systems that will carry Molecule into its next chapter Here’s a quick wrap of what we’ve built -- and what’s coming next

Fox03 is a research project backed by @vitadao, developing a new RNA therapeutic that shifts the longevity-linked FOXO3 gene into its health-promoting form and targeting the tissue breakdown behind degenerative disc disease. A precise, scalable route to drugs that extend healthspan - on Molecule ↓

Relieva targets pain relief through a proprietary cannabinoid-terpene formulation engineered for consistent, replicable results. A functional hemp therapeutic build from controlled chemistry -- now live on Molecule↓

The next Alzheimer's breakthrough may come from shutting off one protein. And 1,900+ people just backed the research to test it. $GALE closed 14.2x oversubscribed, with $712K USDC committed, to support a new approach that targets Alzheimer’s at its root: chronic inflammation.↓

Molecule Labs is evolving, piece-by-piece, line-by-line This week, our product & engineering teams are sketching the outlines of 2026. DeSci applies blockchain -- this century’s most powerful invention --to science’s most broken systems Let's put the devs to work

We've opened a talking slot for DeSci Abu Dhabi - apply to speak to the DeSci community, hosted at the @ClevelandClinic During the same week as @f1, @SolanaConf, @binance Blockchain Week & @bitcoinmenaconf 🔗 below!

NEURON GALE is now live and trading on Molecule -- the only platform where you can track Alzheimer’s research milestones transparently and directly onchain 🧵⤵️

Across the desert, we’ll gather to explore the future of science - one day of deep talks, reflection, and community at DeSci Abu Dhabi. Hosted at the @ClevelandClinic, a modern altar of medicine. December 10. Sign up to attend. More details to follow. luma.com/DeSciAbuDha...

The funding stack for science is being rebuilt. Beyond VC and grants, a new model is forming -- where capital, incentives, and ownership move on open rails. A shift from static institutions ➝ liquid networks of discovery ↓

The smallest errors in our genetic code can cause the biggest failures in our cells. $VITARNA targets nonsense mutations, one of the root causes of aging and disease. Backed by @vitadao, decentralized longevity science, live onchain. ↓

From our screener: @BeeARDai -- an AI-powered multi-agent system mapping the psychedelic frontier. Backed by @psy_dao, BeeARD turns literature, data, and experimental results into a decentralized knowledge graph that learns continuously.

The first human trials for reversing aging are coming. Life Biosciences plans to clinically testing a therapy that targets aging by 2026. Aging is becoming a testable target. The clock isn’t unstoppable anymore. ↓

Today science sits in silos. Tomorrow it lives in markets.

Big congrats to $VITARNA's lead researcher, @Mykalt45, for being awarded Best New Drug Developer at this year's World ADC! 🏆 twitter.com/Mykalt45/st...">November

From our screener: $AUBRAI -- the world's first BioAgent generating and owning onchain IP. Trained on the mind of @aubreydegrey, powered by @Bioprotocol + Molecule's Proof of Invention rails. Build for onchain science acceleration👇

Perplexity's Patents AI agent makes IP searchable. But discovery is only the start. The future of IP isn't just information--it's composability. 👇

Millions of patents are now more accessible than ever. We’re moving from closed‑lab discovery to an open‑web world where: > IP is transparent and searchable by all > Funding is liquid and decentralized > Research progress is visible as it unfolds twitter.com/perplexity_...">October

Science is still running on feudal infrastructure. New systems are inevitable.

Bio/acc

Traditional science funding is in crisis. Meanwhile, tokenized IP is accelerating. Molecule connects breakthrough science with a breakthrough market.

A novel neurodegeneration therapy -- sourced → vetted → funded → executing onchain. @Transfidelity_ is a DeSci project through and through, capturing what is possible when scientific talent meets onchain infrastructure. twitter.com/oxMichelang...">October

A novel neurodegeneration therapy -- sourced → vetted → funded → executing onchain. @Transfidelity_ is a DeSci project through and through, capturing what is possible when scientific talent meets onchain infrastructure. x.com/oxMichelang...

our team is hosting a desci talk & workshop at Berlin Science Week as science takes over the city we're looking to onboard serious academic talent - see the event for more details! x.com/ellamccp/st...

Last week, an AI model imagined a cancer treatment -- and got it right. This week, DrugReflector finds useful compounds 17x faster than traditional research. The lab is turning into a thinking system -- recursive, transparent, self-improving. 👇

We’re optimizing for safety, not discovery -- producing endless variations of the same drug. @fedichev explains how Pharma's risk aversion is dangerous for innovation.

For a decade, US Supreme Court rulings pulled biotech inventions into "abstract ideas". The new PERA (Patent Eligibility Restoration Act) could redraw the innovation landscape > It redefines what's patentable across biotech, AI, and diagnostics -- potentially ending years of uncertainty.

An AI model just made -- and experimentally proved -- a new cancer discovery. Google & Yale’s Cell2Sentence-Scale (27B) generated a hypothesis that turned out to be correct in living cells. Scientific singularity is already happening. 👇

If developers spent 80% of their time applying to buy a keyboard, tech would be stuck in 1995. That’s science today -- researchers spend 80% of their time chasing grants, not breakthroughs. DeSci aims to fix this.

the longest-living rodent on Earth lives 10x longer than its peers. now we know why. a new science paper shows 4 amino acid changes in naked mole-rat cGAS flip a biological switch. from immune triggering ➝ to DNA repairing longevity isn't fiction, it's an engineering problem.👇

$VITASTEM is live on Molecule! Aging starts in your blood. $VITASTEM is the first @Aubrai_-generated IP Token targeting your body’s blood-forming stem cells -- the source of age-related decline. 👇